Facebook tracking pixelType 1 Diabetes Mellitus - AI-Powered ICD-10 Documentation
E10.9
ICD-10-CM
Type 1 Diabetes Mellitus

Find comprehensive information on Type 1 Diabetes Mellitus diagnosis, including ICD-10 codes E10.9 and E10, clinical documentation requirements, diagnostic criteria, and healthcare management guidelines. Learn about blood glucose monitoring, insulin therapy, diabetic ketoacidosis (DKA) management, and long-term complications. This resource provides essential information for healthcare professionals, medical coders, and individuals seeking to understand Type 1 diabetes diagnosis and treatment.

Also known as

Insulin-dependent diabetes
Juvenile diabetes
Insulin-Dependent Diabetes Mellitus (IDDM)
+1 more

Diagnosis Snapshot

Key Facts
  • Definition : Autoimmune disease destroying insulin-producing cells.
  • Clinical Signs : Frequent urination, excessive thirst, unexplained weight loss, increased hunger.
  • Common Settings : Endocrinologist office, primary care clinic, diabetes education center.

Related ICD-10 Code Ranges

Complete code families applicable to AAPC E10.9 Coding
E10

Type 1 diabetes mellitus

Covers all forms of type 1 diabetes.

E10.2

Type 1 DM with ketoacidosis

Type 1 diabetes with diabetic ketoacidosis.

E10.3

Type 1 DM with kidney disease

Type 1 diabetes with nephropathy.

E10.4

Type 1 DM with eye disease

Type 1 diabetes with ophthalmic complications.

Code-Specific Guidance

Decision Tree for

Follow this step-by-step guide to choose the correct ICD-10 code.

Is it Type 1 Diabetes Mellitus?

  • Yes

    With proliferative diabetic retinopathy?

  • No

    Do NOT code as Type 1 Diabetes. Review patient record for correct diagnosis.

Code Comparison

Related Codes Comparison

When to use each related code

Description
Type 1 Diabetes Mellitus
Latent Autoimmune Diabetes in Adults (LADA)
Secondary Diabetes Mellitus

Documentation Best Practices

Documentation Checklist
  • Type 1 diabetes mellitus diagnosis documentation
  • ICD-10-CM code E10.9 confirmation
  • Fasting plasma glucose 126 mg/dL or higher
  • Random plasma glucose 200 mg/dL or higher, with symptoms
  • HbA1c 6.5% or higher, using standardized assay

Coding and Audit Risks

Common Risks
  • Unspecified DM Type

    Coding E11.9 (Type 1 DM, unspecified) when a more specific code (e.g., with complication) is documented, impacting DRG and quality reporting.

  • Unconfirmed Diagnosis

    Coding Type 1 DM based on probable or suspected diagnosis without confirmatory lab results, leading to inaccurate reporting and potential denial.

  • Comorbidity Omission

    Failing to capture and code associated complications like diabetic nephropathy or retinopathy, understating patient complexity and resource utilization.

Mitigation Tips

Best Practices
  • Accurate ICD-10-CM E10.x coding for T1DM diagnosis specificity.
  • Detailed HPI & exam: Insulin dependence onset, symptoms, family history.
  • Consistent lab documentation: C-peptide, autoantibodies, glucose levels.
  • Regular CDI reviews: Ensure T1DM vs T2DM differentiation clarity.
  • Adhere to HIPAA guidelines for T1DM data management & patient privacy.

Clinical Decision Support

Checklist
  • 1. Fasting plasma glucose >= 126 mg/dL (ICD-10 E10.9)
  • 2. Random glucose >= 200 mg/dL + symptoms (E10.9)
  • 3. A1C >= 6.5% (E10.9) document units
  • 4. Ketones present (E10.1 if DKA)

Reimbursement and Quality Metrics

Impact Summary
  • Type 1 Diabetes Mellitus Reimbursement: Coding accuracy impacts payer reimbursements. Optimize E11.- coding for maximum reimbursement.
  • Quality Metrics Impact: HbA1c reporting affects quality scores and value-based payments. Accurate documentation is crucial.
  • Hospital Reporting: Diabetes coding and documentation directly impact hospital quality reporting and public image.
  • Financial Impact: Correct coding (E11.-, Z79.4) minimizes claim denials and optimizes revenue cycle management.

Streamline Your Medical Coding

Let S10.AI help you select the most accurate ICD-10 codes for . Our AI-powered assistant ensures compliance and reduces coding errors.

Quick Tips

Practical Coding Tips
  • Code E10.9 for T1DM unspecified
  • Confirm T1DM diagnosis documentation
  • Query physician if T1DM type unclear
  • Document insulin dependency clearly
  • Exclude secondary diabetes codes

Documentation Templates

Patient presents with classic symptoms of type 1 diabetes mellitus, including polyuria, polydipsia, polyphagia, and recent unexplained weight loss.  The patient reports increased frequency of urination, excessive thirst, and constant hunger despite increased food intake.  Onset of symptoms has been gradual over the past few weeks.  Family history is negative for type 1 diabetes but includes type 2 diabetes mellitus in a maternal grandparent.  Physical examination reveals dry mucous membranes.  Initial point-of-care blood glucose is significantly elevated.  Laboratory findings confirm hyperglycemia, and the presence of autoantibodies such as islet cell cytoplasmic autoantibodies (ICA), glutamic acid decarboxylase autoantibodies (GADA), or insulin autoantibodies (IAA) supports the diagnosis.  HbA1c is elevated, indicating chronic hyperglycemia.  Urinalysis reveals glycosuria and ketonuria, suggestive of inadequate insulin production.  Differential diagnoses considered include type 2 diabetes mellitus and maturity-onset diabetes of the young (MODY).  However, the patient's age, clinical presentation, and laboratory results are more consistent with type 1 diabetes mellitus.  The patient has been educated on diabetes management, including insulin therapy, blood glucose monitoring, carbohydrate counting, and the importance of regular follow-up with an endocrinologist.  An insulin regimen, including basal and bolus insulin, has been initiated.  Dietary counseling has been provided, and the patient has been referred to a certified diabetes educator for comprehensive diabetes self-management education and support.  The patient understands the importance of recognizing and treating hypoglycemia and hyperglycemia.  Follow-up appointment scheduled in two weeks to assess glycemic control and adjust insulin therapy as needed.  Diagnosis: Type 1 diabetes mellitus (ICD-10-CM E10.9).